NCT05930925 - A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

July 27, 2023

Study Completion Date

August 14, 2023

Conditions

Healthy

Interventions

DRUG

[phenyl-14C]ARV-471

Participants will receive a single dose of \[phenyl-14C\]ARV-471 by mouth

DRUG

[oxoisoindolin-14C]ARV-471

Participants will receive a single dose of \[oxoisoindolin-14C\]ARV-471 by mouth

Trial Locations (1)

PPD Phase I Clinic, Austin